Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apollo Medical Inc.

    NASDAQ: AMEH · Real-Time Price · USD
    40.82
    -0.88 (-2.11%)
    At close: Feb 23, 2024, 10:00 PM

    Apollo Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 n/a 620.39M 1B 478.71M 486.26M 353.04M 348.17M 348.21M 337.24M 294.21M 317M 269.7M 263.26M 195.1M 227.12M 175.64M 176.06M
    Cost of Revenue
    		 n/a n/a 857.65M n/a n/a 314.06M 275.38M 292.88M 289.4M 253.12M 240.77M 230.07M 220.73M 171.84M 147.47M 136.21M 140.62M
    Gross Profit
    		 n/a n/a -175.98M n/a n/a 38.98M 72.8M 55.33M 47.85M 41.09M 76.23M 39.63M 42.53M 23.26M 79.64M 39.42M 35.44M
    Operating Income
    		 n/a 20.58M 865K 28.43M 30.07M -3.87M 39.08M 27.03M 22.37M 12.58M 50.09M 15.38M 26.21M 2.25M 53.16M 20.99M 21.78M
    Interest Income
    		 2.34M 2.31M 4.89M 3.78M 3.51M 4.59M 3.28M 3.33M 3.01M 1.29M 223K 421K 46K 240K 420K 563K 349K
    Pretax Income
    		 16.82M 9.6M -8.1M 26.81M 31.9M 924K 38.02M 31.49M 19.41M 10.46M 41.26M 16.63M 18.27M -22.43M -5.5M 84.45M 21.23M
    Net Income
    		 9.42M 6.69M -8.01M 16.09M 19.17M 12.36M 22.06M 13.17M 13.13M -2.6M 23.18M 11.95M 13.76M 13.77M 34.28M 12.66M 13.15M
    Selling & General & Admin
    		 n/a 43.9M 79.46M 37.8M 35.95M 37.95M 29.41M 24.06M 21.18M 24.45M 21.39M 19.89M 11.94M 16.6M 21.81M 14.2M 9.46M
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a n/a n/a 1.86M 1.88M 1.19M 1.2M 1.62M -1.32M 3.03M 613K 10.33M 500K -15.88M 1.3M
    Operating Expenses
    		 n/a 43.9M 79.46M 37.8M 35.95M 42.85M 33.72M 28.3M 25.47M 28.51M 26.14M 24.25M 16.32M 21.01M 26.48M 18.44M 13.66M
    Interest Expense
    		 -7.38M -7.31M -43.78M -8.86M -8.59M 5.42M 3.78M 3.63M 3.27M 2.57M 2.42M 1.85M 1.07M 1.05M 967K 1.85M 1.52M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 n/a n/a 937.11M n/a n/a 356.91M 309.09M 321.18M 314.87M 281.63M 266.91M 254.31M 237.05M 192.85M 173.96M 154.65M 154.28M
    Income Tax Expense
    		 6.61M 3.38M -86K 7.83M 10.03M 1.02M 10.04M 14.01M 6.92M 9.98M 17.37M 5.35M 6.82M -3.12M -120K 24.92M 6.78M
    Shares Outstanding (Basic)
    		 n/a 47.52M 47.52M 47.52M 47.52M 47.52M 46.55M 46.48M 46.56M 43.33M 44.95M 44.86M 44.68M 44.42M 44.3M 44.17M 42.34M
    Shares Outstanding (Diluted)
    		 n/a 47.52M 47.52M 47.52M 47.52M 47.52M 46.92M 46.78M 46.95M 43.33M 46.15M 46.02M 45.99M 45.9M 46.27M 45.83M 43.57M
    EPS (Basic)
    		 0.19 0.14 -0.12 0.34 0.40 0.26 0.47 0.28 0.28 -0.06 0.52 0.27 0.31 0.31 0.77 0.29 0.31
    EPS (Diluted)
    		 0.19 0.14 -0.13 0.33 0.40 0.26 0.47 0.28 0.28 -0.06 0.50 0.26 0.30 0.30 0.74 0.28 0.30
    EBITDA
    		 n/a 9.62M -40.63M 420.29M 433.42M 9.95M 46.44M 38.51M 33.36M 20.77M 55.2M 24.7M 32.68M 16.6M 58.88M 6.77M 26.95M
    EBIT
    		 n/a n/a -99.59M n/a n/a n/a 41.79M 35.12M 22.68M 13.03M 43.69M 18.48M 19.34M -21.38M -4.54M 86.3M 22.76M
    Depreciation & Amortization
    		 n/a 6.85M 8.44M 405.22M 412.81M 4.9M 4.25M 4.25M 10.99M 8.19M 5.11M 9.32M 6.47M 4.41M 4.67M 4.24M 4.2M

    Add to Watchlist